KLRS · Kalaris Therapeutics, Inc. · Debt
Market Cap
$80.46M
Shares
23.80M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1754068
CUSIP
482929106
13F (30d)
23 filings
23 filers
Visit website
Investor relations